under the brand names Ozempic and Wegovy. The data show that the combination of nasal anti-CD3 plus semaglutide improves liver homeostasis and reduces inflammation in models of diet-induced ...

Semaglutide, the scientific name for Novo’s GLP-1 diabetes drug Ozempic and obesity drug Wegovy, has been on the shortage list for over two years, with different doses being listed in shortage ...

Telehealth companies selling low-cost, compounded versions of popular weight-loss drugs, including Ozempic and Wegovy, are drawing increased interest from employers, Bloomberg reported Oct. 29.

Click now to see all the available groups. MONDAY, Oct. 28, 2024 (HealthDay News) -- The weight-loss drug Ozempic can guard against kidney disease in obese people, a new study shows. Patients ...

Semaglutide appears to protect against kidney disease in obese people Taking the drug reduced kidney damage by as much as 52% Patients also had a 30% reduction in kidney inflammation MONDAY, Oct ...

The "About Damn Time" singer shared pics of herself in costume Oct. 26, a month after she brushed off several fans' allegations that she used Ozempic to achieve the slimmer figure she had recently ...